Navigation Links
Parkway Clinical Laboratories Expands Management Team to Support a National Growth Strategy Centered on Oral Fluid Drug Screening
Date:1/7/2008

rbs between downtown Philadelphia and the countryside of Bucks County. The laboratory has been a trusted partner delivering in-vitro diagnostic services for nearly four decades. For more information about PCL visit http://www.parkwayclinical.com.


'/>"/>
SOURCE Parkway Clinical Laboratories
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Philadelphia Insurance Companies to Sponsor the 2007 Parkway Run/Walk
2. Ardea Biosciences Lead NNRTI for HIV, RDEA806, to Enter Phase 2a Proof-of- Concept Clinical Trial
3. ADA Issues New Clinical Practice Recommendations
4. Immtech Announces Pafuramidine (DB289) Program on Clinical Hold
5. Menopausal Women May Have an Increased Asthma Risk, From The Journal of Allergy and Clinical Immunology
6. New Book Looks at Clinical Research from the Patients Point of View
7. Xeloda(R), Taxotere(R) and Herceptin(R) Combination Study Suggests Clinical Benefit in Invasive Breast Cancer with Shortened Treatment Cycle
8. QRxPharma Initiates Second Phase III Clinical Trial for its Dual Opioid Pain Therapy
9. Advanced Clinical Research Services Enhances Biostatistics Offering
10. Sunesis Pharmaceuticals SNS-595 Shows Clinical Activity in Patients With Relapsed or Refractory Acute Leukemias; Data Presented in Oral Session at 49th Annual Meeting of the American Society of Hematology
11. Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...popular drugs do not cause genetic damage that can...althDay News) -- Two popular medications for treat...) do not cause genetic damage linked to an increas..., The study, done by researchers at Duke Univers...Health, counters a previous one that reported biom...
(Date:11/21/2008)...1 In a statewide survey, 33 physic...te for Surgery at Presbyterian Hospital of Dallas ... listing of " Super Doctors ." , , Each yea... Professional Media, Inc. to survey more than 38,0... to ask, "If you needed medical care, which doctor...
(Date:11/21/2008)...Nov. 21 Symmetry Medical...er of products to the global orthopedic device ind...hat Brian S. Moore, President and Chief Executive ...nd Chief Financial Officer, are scheduled to prese...nference at The New York Palace Hotel on Wednesday...
(Date:11/21/2008)...y, Panama - The University of Texas M. D. Anderson...tive effort to eradicate breast cancer in Panama t... and Research of the Americas today at an event wi..., and Vivian Fernndez de Torrijos, the First Lady ...tiative are the U.S. Department of State and Susan...
Breaking Medicine News(10 mins):Health News:ADHD Medications Don't Pose Cancer Risk 2Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research extends to Panama 2
...elps to protect the lungs of premature infants fro...McMaster University researchers have reported// an...ss the safety of caffeine therapy for the treatmen... prematurity is very common in preterm infants, be...
...sexes involving themselves in dangerous behaviors ...ts a new study// supported by the National Institu...Health. The following result, concluded from the r...enagers can be cited in the Archives of Women’s Me...
...makers decided on Tuesday that food companies will...cts any longer. //The decision marks the first tim...g claims or health benefits on the food labels. EU...ard for vitamins, minerals and food additives. The...
... Rights Commission (NHRC) on Wednesday questioned ...as taken against the 21 medicos who involved //in ...ment should submit the report in four weeks," said...y the commission. Soon after a report was publis...
Other Medicine News:Health News:Caffeine Therapy May Help Protect Lungs Of Premature Babies 2Health News:Risky Behavior In Teenagers Leads To Depression 2
(Date:11/13/2008)...rstCall/ -- Hologic, Inc.,(Nasdaq: HOLX ), a lead...m,diagnostics, medical imaging systems and surgica...ds of women, today announced the results of the,Ce...ervista HPV high-risk,test is currently under revi...unched in the European Union (EU) early in 2009. T...
(Date:11/13/2008)...Cut Risk of Heart Attacks, Deaths, RESTON, Va., N...isease,is the leading cause of death among America...ions of dollars and causing untold suffering. Now,...e - even among those who,weren,t thought to be at ...ple could cut their risk of a,heart attack, stroke...
(Date:11/12/2008)...on, Marilyn & James Simons and,Sherry Lansing at G... J. Craig Venter,Ph.D.,...itute (JCVI), was,awarded the Double Helix Medal f...er 6th at a gala event in New York City., Dr. Ven... James D.,Watson for making each of their individu...
(Date:11/12/2008)...versible, High-level Platelet Inhibit... and SOUTH SAN FRANCISCO, Calif., Nov. 12 /PRNewsw...al company developing innovative,drugs that provid...mmatory,diseases, and cancer, today announced new ...any,s novel anti-platelet drug that directly and,r...
Breaking Medicine Technology:Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 3Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 4Seniors Can Be Heartened by New Study on Statins 2J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory 2Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix(R)) Non-Responders 2Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix(R)) Non-Responders 3Recovery from acid rain much slower than expected 607 1Recovery from acid rain much slower than expected 607 2Genomic profiling of lung tumors helps doctors choose most effective treatment 2322 1Genomic profiling of lung tumors helps doctors choose most effective treatment 2322 2Genomic profiling of lung tumors helps doctors choose most effective treatment 2322 3Transcept Pharmaceuticals Inc to Present at 2007 BIO Investor Forum 2317 1Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs 929 1Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs 929 2Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs 929 3Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs 929 4
...raxis BioScience,Inc. (NASDAQ:ABBI), an integrate...ults from two pre-clinical studies that,provide ev...ationale for combining nab-paclitaxel (ABRAXANE(R)...nd particles for injectable,suspension) (albumin-b...(Avastin(R)) at the 98th American Association for,...
...stCall/--,EntreMed, Inc. , a clinical-stage pharma...reatment of cancer and inflammatory diseases,toda...s for MKC-1,its novel cell cycle inhibitor. The d...merican Association for Cancer Research (AACR),Ann...alifornia. , MKC-1 is a novel, orally-active cell ...
Other Medicine Technology:Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 2Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 3Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 4Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 5EntreMed Presents Preclinical Data for MKC-1 in Hematological,Cancers 2EntreMed Presents Preclinical Data for MKC-1 in Hematological,Cancers 3EntreMed Presents Preclinical Data for MKC-1 in Hematological,Cancers 4
The VASER System represents a major advance in the application of ultrasonic technology to cosmetic procedures. Combined with precision fluid management, controlled and selective tissue emulsificatio
Bookler Richardson Blade Set - for use with Bookler Universal Table Mounted Retractor Systems
...sive is a new term being used today to describe th...ill that may have been used in silicone implants i...s not new technology cohesive is simply a word th...ther nature of the gel. All of Mentor silicone gel...
Inquire
Medicine Products: